Skip to main content
. 2024 Apr 9;16(8):1448. doi: 10.3390/cancers16081448

Figure 2.

Figure 2

(A) Remission duration after two courses of induction therapy with ADE (n = 164) or (B) ADE+BTZ (n = 210) in treated patients with high HME levels (red) compared to those with low HME levels (blue). Remission duration after two courses of induction therapy in (C) the low-HME and (D) high-HME populations separately in ADE vs. ADE+BTZ treatment regimes. Overall survival in (E) low-HME and (F) high-HME profile patients in ADE vs. ADE+BTZ.